Literature DB >> 25659996

Intestinal vascular endothelial growth factor is decreased in necrotizing enterocolitis.

Animesh Sabnis1, Rosa Carrasco, Shirley X L Liu, Xiaocai Yan, Elizabeth Managlia, Pauline M Chou, Xiao-Di Tan, Isabelle G De Plaen.   

Abstract

BACKGROUND: Decreased intestinal perfusion may contribute to the development of necrotizing enterocolitis (NEC). Vascular endothelial growth factor (VEGF) is an angiogenic protein necessary for the development and maintenance of capillary networks. Whether VEGF is dysregulated in NEC remains unknown.
OBJECTIVES: The objective of this study was to determine whether intestinal VEGF expression is altered in a neonatal mouse model of NEC and in human NEC patients.
METHODS: We first assessed changes of intestinal VEGF mRNA and protein in a neonatal mouse NEC model before significant injury occurs. We then examined whether exposure to formula feeding, bacterial inoculation, cold stress and/or intermittent hypoxia affected intestinal VEGF expression. Last, we visualized VEGF protein in intestinal tissues of murine and human NEC and control cases by immunohistochemistry.
RESULTS: Intestinal VEGF protein and mRNA were significantly decreased in pups exposed to the NEC protocol compared to controls. Hypoxia, cold stress and commensal bacteria, when administered together, significantly downregulated intestinal VEGF expression, while they had no significant effect when given alone. VEGF was localized to a few single intestinal epithelial cells and some cells of the lamina propria and myenteric plexus. VEGF staining was decreased in murine and human NEC intestines when compared to control tissues.
CONCLUSION: Intestinal VEGF protein is reduced in human and experimental NEC. Decreased VEGF production might contribute to NEC pathogenesis.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25659996      PMCID: PMC4354688          DOI: 10.1159/000368879

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  27 in total

Review 1.  Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease.

Authors:  Steven H Abman
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Expression, localization and systemic concentration of vascular endothelial growth factor (VEGF) and its receptors in patients with ulcerative colitis.

Authors:  Dorota Frysz-Naglak; Bogusława Fryc; Ewa Klimacka-Nawrot; Urszula Mazurek; Wanda Suchecka; Maciej Kajor; Józef Kurek; Antoni Stadnicki
Journal:  Int Immunopharmacol       Date:  2010-11-27       Impact factor: 4.932

3.  Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells.

Authors:  C G Siafakas; F Anatolitou; R D Fusunyan; W A Walker; I R Sanderson
Journal:  Pediatr Res       Date:  1999-05       Impact factor: 3.756

4.  Endothelin-1 in human intestine resected for necrotizing enterocolitis.

Authors:  Philip T Nowicki; David J Dunaway; Craig A Nankervis; Peter J Giannone; Peter J Giannnone; Kristina M Reber; Susan B Hammond; Gail E Besner; Donna A Caniano
Journal:  J Pediatr       Date:  2005-06       Impact factor: 4.406

5.  Genetic polymorphisms for vascular endothelial growth factor in perinatal complications.

Authors:  Ilona Bányász; Géza Bokodi; Barna Vásárhelyi; András Treszl; László Derzbach; András Szabó; Tivadar Tulassay; Adám Vannay
Journal:  Eur Cytokine Netw       Date:  2006-12       Impact factor: 2.737

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.

Authors:  Bernadette M Levesque; Leslie A Kalish; Abigail B Winston; Richard B Parad; Sonia Hernandez-Diaz; Michele Phillips; Amy Zolit; JoAnn Morey; Munish Gupta; Akiko Mammoto; Donald E Ingber; Linda J Van Marter
Journal:  Neonatology       Date:  2013-05-24       Impact factor: 4.035

8.  Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels.

Authors:  Chris M van der Loos; Lorine B Meijer-Jorna; Marloes E C Broekmans; Hanneke P H M Ploegmakers; Peter Teeling; Onno J de Boer; Allard C van der Wal
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

9.  Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.

Authors:  G Tsiolakidou; I E Koutroubakis; M Tzardi; E A Kouroumalis
Journal:  Dig Liver Dis       Date:  2008-04-18       Impact factor: 4.088

10.  Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice.

Authors:  Shirley X L Liu; Runlan Tian; Heather Baskind; Wei Hsueh; Isabelle G De Plaen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-21       Impact factor: 4.052

View more
  14 in total

1.  Milk growth factors and expression of small intestinal growth factor receptors during the perinatal period in mice.

Authors:  Man Zhang; Yalin Liao; Bo Lönnerdal
Journal:  Pediatr Res       Date:  2016-09-07       Impact factor: 3.756

2.  Prenatal inflammation impairs intestinal microvascular development through a TNF-dependent mechanism and predisposes newborn mice to necrotizing enterocolitis.

Authors:  Xiaocai Yan; Elizabeth Managlia; Xiao-Di Tan; Isabelle G De Plaen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-05-24       Impact factor: 4.052

Review 3.  Recent Advances in Necrotizing Enterocolitis Research: Strategies for Implementation in Clinical Practice.

Authors:  Mohan Pammi; Isabelle G De Plaen; Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2020-03-04       Impact factor: 3.430

4.  Non-coding RNAs in Neonatal Necrotizing Enterocolitis.

Authors:  Keyur Donda; Benjamin A Torres; Akhil Maheshwari
Journal:  Newborn (Clarksville)       Date:  2022-03-31

5.  Role of the Endothelium in Neonatal Diseases.

Authors:  Olachi J Mezu-Ndubuisi; Akhil Maheshwari
Journal:  Newborn (Clarksville)       Date:  2022-03-31

6.  Lack of VEGFR2 signaling causes maldevelopment of the intestinal microvasculature and facilitates necrotizing enterocolitis in neonatal mice.

Authors:  Xiaocai Yan; Elizabeth Managlia; Shirley Xl Liu; Xiao-Di Tan; Xiao Wang; Catherine Marek; Isabelle G De Plaen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-25       Impact factor: 4.052

7.  Loss of endothelial nitric oxide synthase exacerbates intestinal and lung injury in experimental necrotizing enterocolitis.

Authors:  Natalie A Drucker; Amanda R Jensen; Jan P Te Winkel; Michael J Ferkowicz; Troy A Markel
Journal:  J Pediatr Surg       Date:  2018-03-08       Impact factor: 2.545

Review 8.  Advances in our understanding of the molecular pathogenesis of necrotizing enterocolitis.

Authors:  Xue Cai; Alena Golubkova; Catherine J Hunter
Journal:  BMC Pediatr       Date:  2022-04-25       Impact factor: 2.567

9.  Vascular Endothelial Growth Factor (VEGF) Bioavailability Regulates Angiogenesis and Intestinal Stem and Progenitor Cell Proliferation during Postnatal Small Intestinal Development.

Authors:  Christopher R Schlieve; Salvador Garcia Mojica; Kathleen A Holoyda; Xiaogang Hou; Kathryn L Fowler; Tracy C Grikscheit
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

10.  Dimethyloxalylglycine preserves the intestinal microvasculature and protects against intestinal injury in a neonatal mouse NEC model: role of VEGF signaling.

Authors:  Rakhee M Bowker; Xiaocai Yan; Elizabeth Managlia; Shirley X L Liu; Catherine Marek; Xiao-Di Tan; Isabelle G De Plaen
Journal:  Pediatr Res       Date:  2017-10-25       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.